● Recruiting

A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer

Condition: Locally Advanced Resectable Rectal Cancer · Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

PhasePhase 2/Phase 3

Planned participants165

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

The study is being conducted to evaluate the safety and efficacy of Adebrelimab and SHR-8068 in combination with chemoradiotherapy in subjects with rectal cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Chuanpei Huang · +86-021-61053363 · chuanpei.huang@hengrui.com

Always discuss trial participation with your own doctor first.

Locations (2)

Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology	Wuhan, Hubei, China	Recruiting
Zhejiang Cancer Hospital	Hangzhou, Zhejiang, China	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07454720